
    
      A 52-week treatment, multicenter, randomized, open-label, parallel-group study to assess the
      efficacy of NVA237 (50μg once daily) using Tiotropium (5μg once daily) as an active control
      in Brazilian patients with moderate to severe Chronic Obstructive Pulmonary Disease.
    
  